Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 3/20 | 0.45 |
| ▸ | CES1 | P23141 | 3/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2963910 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2970782 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2975988 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2969844 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2972857 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2973389 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2973223 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2963713 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2971244 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 | |
| SCHEMBL2966532 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250236755-A1 | COATING COMPOSITION AND METHOD FOR FORMING COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2025-07-24 | — | — | US | disclosed |
| EP-4481009-A1 | COATING COMPOSITION AND METHOD FOR FORMING COATING FILM | Kansai Paint Co., Ltd. (JP) | 2024-12-25 | — | — | EP | disclosed |
| US-7763562-B2 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
| US-7214746-B2 | Phosphorus bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-08 | — | — | US | disclosed |
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | PYM1, ZNF207, POLL | TSHR 3182/4885THRB 3850/4885ALDH1A1 4206/4885 |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | TSHR 551/4885THRB 454/4885ALDH1A1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.